1. Home
  2. BNR vs HGBL Comparison

BNR vs HGBL Comparison

Compare BNR & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • HGBL
  • Stock Information
  • Founded
  • BNR 2014
  • HGBL 1937
  • Country
  • BNR China
  • HGBL United States
  • Employees
  • BNR N/A
  • HGBL N/A
  • Industry
  • BNR Medical Specialities
  • HGBL Business Services
  • Sector
  • BNR Health Care
  • HGBL Consumer Discretionary
  • Exchange
  • BNR Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • BNR 72.4M
  • HGBL 72.0M
  • IPO Year
  • BNR 2020
  • HGBL N/A
  • Fundamental
  • Price
  • BNR $7.32
  • HGBL $2.10
  • Analyst Decision
  • BNR
  • HGBL
  • Analyst Count
  • BNR 0
  • HGBL 0
  • Target Price
  • BNR N/A
  • HGBL N/A
  • AVG Volume (30 Days)
  • BNR 5.5K
  • HGBL 87.3K
  • Earning Date
  • BNR 12-03-2024
  • HGBL 03-13-2025
  • Dividend Yield
  • BNR N/A
  • HGBL N/A
  • EPS Growth
  • BNR N/A
  • HGBL N/A
  • EPS
  • BNR N/A
  • HGBL 0.27
  • Revenue
  • BNR $72,832,704.00
  • HGBL $49,878,000.00
  • Revenue This Year
  • BNR $52.90
  • HGBL N/A
  • Revenue Next Year
  • BNR $48.35
  • HGBL $19.47
  • P/E Ratio
  • BNR N/A
  • HGBL $7.82
  • Revenue Growth
  • BNR N/A
  • HGBL N/A
  • 52 Week Low
  • BNR $2.62
  • HGBL $1.52
  • 52 Week High
  • BNR $9.50
  • HGBL $3.09
  • Technical
  • Relative Strength Index (RSI)
  • BNR 63.72
  • HGBL 75.28
  • Support Level
  • BNR $6.68
  • HGBL $2.02
  • Resistance Level
  • BNR $7.32
  • HGBL $2.12
  • Average True Range (ATR)
  • BNR 0.23
  • HGBL 0.08
  • MACD
  • BNR -0.04
  • HGBL 0.01
  • Stochastic Oscillator
  • BNR 93.63
  • HGBL 91.23

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a global full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: